ycobacterium terrae complex (MTC) was first characterized in 1981 by the International Working Group in Mycobacterial Taxonomy (IWGMT). The initial MTC consisted of two nonchromogenic slowly growing species: M. terrae and Mycobacterium nonchromogenicum (1, 2). Phenotypic separation within the group was often difficult, and molecular methods were not available, making establishment of species pathogenicity uncertain (3).
M
ycobacterium terrae complex (MTC) was first characterized in 1981 by the International Working Group in Mycobacterial Taxonomy (IWGMT). The initial MTC consisted of two nonchromogenic slowly growing species: M. terrae and Mycobacterium nonchromogenicum (1, 2) . Phenotypic separation within the group was often difficult, and molecular methods were not available, making establishment of species pathogenicity uncertain (3) .
The complex is recognized as an environmental contaminant of sputum and a cause of tenosynovitis and osteomyelitis primarily of the fingers and wrist . Whether one or more members of the complex are true respiratory pathogens has not been established (1, 22) .
The first published case report of tenosynovitis caused by the MTC was by Hirata and Tomiyama in 1976 (4) . There have been approximately 34 additional case reports published since then, identified using nonmolecular methods , with 14 cases identified using molecular methods (26) (27) (28) (30) (31) (32) (33) (34) (35) (36) (Tables 1 and  2 ). With the exception of four isolates of M. arupense, including the original description of M. arupense (28) , details of the methods and/or explicitly stating a 100% 16S rRNA gene sequence identity to recognized species for the remaining cases with molecular identifications have been absent (Table 2 ).
An excellent history and species update of the M. terrae complex based on multigene sequencing targets was published by Tortoli et al. (1) . He noted that the presence of a two nucleotide insertion in helix 18 of the 16S rRNA gene (bp ϳ430 to 500; hypervariable region B or region V3) provided a consistent signature sequence for members of the MTC compared to other slowly growing mycobacteria (37, 38) . He also characterized several new species in the complex, including Mycobacterium heraklionense and Mycobacterium engbaekii (1) .
The greater availability of DNA sequencing (59) has resulted in a "boom" of new species of MTC, beginning with Mycobacterium hiberniae (39) . An additional eight new species have been validly published since 2006: Mycobacterium arupense (28) , Mycobacterium kumamotonense (36) , Mycobacterium heraklionense (1), Mycobacterium senuense (40) , Mycobacterium minnesotense (41) , My-cobacterium longobardum (1) , Mycobacterium algericum (42) , and Mycobacterium engbaekii (1) . Two other MTC species have been described that currently have no standing in nomenclature: "Mycobacterium paraterrae" (43) and "Mycobacterium sinense" (44) .
Almost all published cases of these 11 new species of the MTC have been respiratory except for the two previously mentioned isolates of M. arupense (including the type strain, ATCC BAA-1242), which were associated with tenosynovitis or hand infections (28) . The distribution of these 11 newer species of the complex as well as the two established members (M. terrae and M. nonchromogenicum) among clinical isolates from synovial fluid, tissue, or bone based on DNA sequencing is not known. Thus, we collected tendon, synovial, and bone isolates of the M. terrae complex recovered over 30 years, including isolates previously identified as M. nonchromogenicum using nonmolecular methods, and subjected them to molecular identification (3) . We also present a case report of osteomyelitis due to a previously unrecognized taxa within the MTC.
CASE REPORT
The patient is a 75-year-old previously healthy male who sustained a chainsaw injury to his leg. DNA extraction. A small loopful of bacteria from isolated colonies was suspended in 100 l of preparation reagent (PrepMan Ultra, Life Technologies, Carlsbad, CA). Samples were held for 30 s and then heat killed for 10 min at 100°C, and then the samples were cooled down at room temperature for 2 min and centrifuged at maximum speed in a microcentrifuge for 2 min. The DNA was extracted by transferring 50 l of the supernatant.
16S rRNA complete gene PCR and sequencing. 16S rRNA complete gene sequencing was performed as previously described by Edwards et al. (45) .
PCR was performed in a 20-l reaction mixture using a 10 M concentration of each of the primers (pA and pH) (45) , 1ϫ FailSafe Premix I, and 1.25 U of FailSafe enzyme mix (Epicentre, Madison, WI). The PCR product (5 l) was run on a 2% agarose gel (Promega, Madison, WI) with EZ safe stain (1 l) (eEnzyme, Gaithersburg, MD) and visualized under UV light using a SYBR gold emission filter.
After purifying the amplicon using USB ExoSap-IT reagent (Affymetrix, Santa Clara, CA), sequencing was performed using primers pC, TABLE 2 Characteristics of 14 previously reported cases of tenosynovitis due to the M. terrae complex based on DNA sequencing Japan/2006 36 a M, male; F, female; com 16S, complete 16S sequence; "16S," base pair not specified; "hsp65," base pair not specified.
b
Data not provided as to whether tenosynovitis was present. However, cellulitis without tenosynovitis has not been described for this group of isolates.
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pD, and pE (45) and a BigDye Terminator v3.1 cycle sequencing kit on an ABI 3500 genetic analyzer according to the manufacturer's instructions (Life Technologies, Carlsbad, CA). Gene sequence analysis was performed using RipSeq software (Isentio AS, Bergen, Norway). Primer regions were excluded, yielding a final sequence of 1,489 bp for all strains (as is the case for members of the M. terrae complex). Sequences were compared to those for validated type strains and all available sequences using RipSeq and NCBI BLAST version 2.3.0ϩ. Three separate NCBI databases were used for BLAST analyses: (i) 16S rRNA sequences (Bacteria and Archaea), (ii) the nucleotide collection (nr/nt), and (iii) whole-genome shotgun contigs (wgs). A separate BLAST analysis using only the first 500 bp from the 5 new species was performed to better assess the presence of similar sequences in the public domain. Interpretation was in accordance with the Clinical and Laboratory Standards Institute (CLSI) interpretive criteria for DNA target sequencing (46) (Table 3) .
rpoB partial gene sequencing. Sequencing of region V and region III of the rpoB gene (720 bp and 315 bp, respectively, excluding the primer regions) was performed on selected isolates, including isolates whose complete 16S rRNA gene sequence was not a 100% match to a validated species type strain as described previously (47, 48) . The nucleotide collection (nr/nt) NCBI database was used for BLAST analyses. hsp65 partial gene sequencing. A 441-bp region of the hsp65 gene was amplified (49) and used for molecular analysis of a 401-bp sequence (excluding the primer regions). Sequencing was done on some of the isolates that are not 100% to a validated type strain by 16S rRNA gene sequencing using the BigDye Terminator v3.1 cycle sequencing kit on an ABI 3500 genetic analyzer. Both the nucleotide collection (nr/nt) and wholegenome shotgun contig (wgs) NCBI databases were used for BLAST analyses.
Phylogenetic analyses. For all gene targets, sequencing alignments of strains from this study and chosen sequences from GenBank were created and phylogenetic analyses were conducted using MEGA version 6 (50). A web-accessible database of hsp65 sequences from Mycobacterium reference strains was also used to populate the hsp65 alignment (51) .
Members of the M. terrae complex are known to harbor two copies of the ribosomal operon that may contain differences in the 16S rRNA gene (52, 53) , seen as ambiguous bases in sequence electropherograms. Variations in positions of ambiguity were not considered in 16S phylogenetic analyses in this study.
Susceptibility testing. Susceptibility testing of the M. terrae complex isolates was performed using broth microdilution according to CLSI guidelines (54) . 
RESULTS

Previous reported cases.
A total of 35 previously published cases of tenosynovitis and osteomyelitis due to members of the M. terrae complex and identified using nonmolecular methods since 1976 were reviewed. Biochemical testing and HPLC were primarily used in the species identification. All cases were previously reported to be due to M. terrae or M. nonchromogenicum. Most (80%) cases involved the hand, fingers, or wrists, with histopathologic findings of granuloma and growth of the organism from operative materials (Table 1) .
A total of 14 cases of tenosynovitis and osteomyelitis due to the M. terrae complex identified using molecular methods were investigated (Table 2 ). In three cases (cases 1, 9, and 12) 16S rRNA gene sequencing was used but did not provide a percent match with a type strain, in one case (case 7) DNA-DNA hybridization was used, and in three cases (cases 2, 3, and 11) no molecular details were given. The first three cases (cases 1 to 3) ( Table 2) were all reported as M. nonchromogenicum. Two isolates (cases 4 and 5, Table 2 ) underwent complete 16S rRNA gene sequencing as well as secondary gene target sequencing as part of the original study describing M. arupense by Cloud et al. in 2006 (28) . One of these (AR 30097 T ) is the recognized type strain of M. arupense, and both isolates were a 100% match of the complete 16S rRNA gene to each other and other identified sputum isolates (28) . In two other cases partial 16S rRNA gene sequencing was used, with 100% match to the type strain of M. arupense (cases 8 and 13) (31, 35) . Two additional case isolates underwent 16S rRNA partial gene sequencing (cases 6 and 10); one reported as M. arupense and the other as M. longobardum, although both were only a 99.2% match to the type strain. The isolate in the last case (no. 14) underwent complete 16S sequencing and was a 99.8% (1,429/1,432 bp) match to M. arupense (36) . By current CLSI standards these last three isolates are grouped as "most closely related") (46, 55) . Overall, based on the provided information, only four isolates met current CLSI sequencing criteria for a specific species identification (cases 4, 5, 8, and 13), and all were identified as M. arupense (46) . Current isolates. A total of 26 patients with available isolates for study were identified (Table 3) . Five of these isolates were identified in the presequencing era (all as M. nonchromogenicum) (3), and 21 were new isolates. The 25 patients from known locations were from 13 states: Texas (5), Missouri (3), Florida (3), Massachusetts (2), California (2), Washington (2), Iowa (1), Arkansas (1), Kansas (1), Maine (1), North Carolina (2), Illinois (1), and Virginia (1). Isolates were from the finger, hand, or wrist (18) (69%), elbow (3) (11.5%), knee (1) (4%), flexor tendon (2) (8%), tibia (1) (4%), and synovial fluid (1) (4%).
16S rRNA complete gene sequencing. By complete 16S rRNA gene sequencing, a 100% identity to a validated type strain sequence (Table 3) Fig. 1]) , a sequence electropherogram of this region revealed the presence of two 16S copies where one sequence contained the gap and the other did not. This resulted in a single base pair shift at that position, making all subsequent sequence data uninterpretable. We considered, then, that this gap could be a feature of some strains of M. kumamotonense and therefore was not considered a true base pair difference.
There were three isolates (MO-233, MO-1300, and MO-5116) with 100% identity to each other but no match to any validated species or other GenBank sequence ("new species") using the top 250 matches from nucleotide collection database. The closest established species were M. arupense, with a mismatch of 5 bp (99.7%), followed by M. nonchromogenicum and M. heraklionense, with mismatches of 9 bp (99.4%) and 10 bp (99.3%), respectively. These isolates and their relationship to other isolates of the M. terrae complex using the complete 16S rRNA gene are shown in The isolate MO-4693 presented with 5 ambiguous bases that could not be resolved upon repeat sequencing from a single colony and are presumed to be due to 2 differing copies of the 16S rRNA gene.
Comparing against nonvalidated species, the closest match for the 5 new species strains was "M. paraterrae" (GenBank accession number EU919229.1), with four base pair mismatches over the full gene. For this reason, the proposed type strain for the species was obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) (DSM 45127) for confirmation and comparison. However, it was determined that the isolate submitted to DSMZ as the type strain of "M. paraterrae" has a strikingly different 16S rRNA gene sequence than that deposited in GenBank, differing from it by 47 bp (96.8%). This was also confirmed in the DSMZ (with a 100% sequence identity to that determined in our facility) and stated on their website along with strain info for DSM 45127 (https://www.dsmz.de/catalogues/details /culture/DSM-45127.html?tx_dsmzresources_pi5%5BreturnPid %5Dϭ304). The complete 16S rRNA gene sequence determined for the strain of "M. paraterrae" presently in the DSMZ collection (DSM 45127) appears to represent a novel species closest to M. cookii ATCC 49103 T (GenBank accession number AF480598) (9-bp difference [99.4% identity]). Interestingly, a BLAST analysis of the corresponding rpoB sequence of "M. paraterrae" previously deposited in GenBank (accession number EU919230) reveals a closest match (283/298 bp [95.0%]) with that of M. cookii CIP105396 T (accession number AY544904). Similarly, BLAST analysis of the corresponding hsp65 sequence of "M. paraterrae" deposited in GenBank (accession number EU919228) reveals a close match only to a single entry (579/583 bp) described as M. cookii-like (accession number JX566891).
Of the five isolates from the 1991 publication by Ridderhof et al. heraklionense, and M. kumamotonense described in this study, and the proposed new species based on neighbor-joining and partial deletion analysis using a site coverage cutoff of 95%. Sequences derived from available whole-genome sequences of members of the M. terrae complex (indicated by "WGS") were also included. Mycobacterium cookii and "Mycobacterium paraterrae" are included as outliers. The bar represents the number of nucleotide differences.
rpoB partial gene sequencing region III. A 315-bp fragment of rpoB region III was analyzed (analysis with a shorter fragment depending on available matches is otherwise indicated). Two of the five members of the new species (MO-233 and MO-1300) had 100% sequence identity to each other by rpoB region III sequencing but differed by 15/305 bp (95.1%) from the type strain of its closest established species, M. arupense. The sequence of the third member (MO-5116) differed from the other two by 15 bp (95.2%) and only by 7/312 bp (97.8%) from its closest species, M. heraklionense. This does not represent the type strain (no examples are available for this region); however, this GenBank entry is from the same reference (and authors) that described the species (1). The sequences of the last two (MO-3559 and MO-4693) differed from the "new species" proposed type strain MO-233 by 17 bp (94.6%) and 16 bp (95.0%), respectively. Their relationship to other members of the M. terrae complex is shown in Fig. 3 .
The isolate with a 1-bp difference (a deletion) in complete 16S rRNA gene sequence from M. kumamotonense (MO-2762) had an rpoB gene region III sequence that differed by only 1 bp (99. Sequence comparisons with non-type strains by BLAST analysis. To assess the presence of the novel species elsewhere, a BLAST analysis was also performed using only the first 500 bp of the 16S rRNA gene, allowing for comparison with GenBank sequences closer to 500 bp in length, as is performed in many clinical laboratories. Sequences of clinical isolates presenting with a 100% match were strains FI-10193 (accession number JN571170.1) (1) and N177 (accession number AY215361.1), both indicated as members of the M. terrae complex. Upon BLAST analysis of the 16S rRNA gene (full) against the whole-genome shotgun contigs (wgs) database, a 99.9 to 100% match (0 to 1 bp) was achieved with 3 of 4 strains obtained from the trunk washes of captive elephants. These strains were described as new genomospecies within the M. terrae complex (56) .
Further investigation against non-type strain sequences was also done using hsp65. With the large number of hsp65 sequences related to the MTC deposited in public sequence databases, many of which are either not identified or misidentified, comparison was restricted to only those with a 100% match. A BLAST analysis (Table 4) .
DISCUSSION
This study clearly demonstrates the inability of phenotypic tests and mycolic acid analysis (HPLC) to recognize newer mycobacterial species defined by DNA sequencing, including members of the M. terrae complex. Tenosynovitis or osteomyelitis caused by members of the M. terrae complex was believed on the basis of phenotypic testing by mycolic acid analysis (HPLC) to be due to M. nonchromogenicum or M. terrae for more than 30 years. The recognition of M. arupense as a cause of tenosynovitis in 2006 (28) was the first indication that other species might be responsible. The current study suggests that neither M. terrae nor M. nonchromogenicum is a cause of tenosynovitis and that earlier isolates identified as these species by nonsequencing methods were misidentified (3).
There is no treatment of choice for M. terrae complex tenosynovitis. Previous reports have noted the benefits of a macrolide combined with one or more additional agents that included ethambutol, rifabutin, and/or a sulfonamide, including trimethoprim-sulfamethoxazole (TMP-SMX) (3, 31) . The major pathogens defined in the current study are M. arupense and M. heraklionense. These species are generally susceptible to clarithromycin, ethambutol, rifabutin, and TMP-SMX. A recent report of susceptibilities of 40 isolates of M. arupense by Beam et al. gave similar results to the current study (31) with 100% of tested isolates susceptible to clarithromycin, ethambutol, and rifabutin, and approximately 50% susceptible to TMP-SMX (31). Five of these 26 isolates (19%) belonged to a previously unrecognized species. Three of the five isolates had 100% sequence identity for their complete 16S rRNA gene and differed by 5 bp from its closest validated species. Three isolates, including the proposed type strain (MO-233, MO-1300, and MO-5116), exhibited Ͼ99% sequence identity for region V of the rpoB gene, the sequence of the hsp65 gene highlighted by Telenti et al., and twothirds of region III of the rpoB gene. Strain MO-3559, however, exhibited Ͻ96.2% identity for these sequences, and MO-4693 exhibited from 97.9% to 95.3% identity for the same sequences. The high degree of variance of the strains MO-3559 and MO-4693 from each other and from the other three strains of the proposed new species possibly indicates emergence of new species that is beyond the scope of this study. The proposed name for the three isolates, "M. virginiense," refers to the geographic location of the first recognized case.
Like the other previous 11 members of the M. terrae group, this new species has a two-nucleotide insertion in helix 18 of the 16S rRNA gene (37, 58) characteristic of members of the M. terrae complex. It also shares other culture features of this group, including lack of pigmentation and growth rate of more than 7 days.
In the current study, one isolate of M. kumamotonense, whose complete 16S rRNA gene sequence differed by one deletion from the type strain, was identified. Given the likelihood of the presence of two ribosomal operons and the high degree of similarity of region V of the rpoB between the current strain and the type strain (99.6%), it is highly likely that the current isolate is M. kumamotonense. The extra base pair occurs within 20 bp of the 3= end of the sequence in GenBank, while the current sequence with the gap is approximately 80 bp longer (1) . Recent studies have shown this species to have two copies of the 16S rRNA gene, and this is the most likely explanation of this single base pair difference (53) .
Description of new species. Isolates of the newly proposed species "M. virginiense" were acid fast, slowly growing, and nonpigmented on Middlebrook 7H10 agar. The isolates were buff colored and grew in Ͼ7 days. They did not grow at 42°C, and their optimal growth temperature was 35°C.
By CLSI guidelines, the isolates were susceptible to clarithromycin, ethambutol, rifabutin, and TMP-SMX and resistant to rifampin, the quinolones, including moxifloxacin, amikacin, and the tetracycline analogues doxycycline and minocycline (54) . Their complete 16S rRNA gene, the hsp65 fragment highlighted by Telenti et al., and regions III and V of the rpoB gene are different from those of other members of the M. terrae complex.
The proposed type strain is MO-233, which is an acid fast slowly growing, nonchromogenic isolate on Middlebrook agar that produced tenosynovitis in a 58-year-old woman from Virginia (case 1 in the paper by Ridderhof et al. [3] ). The isolate was niacin negative, had a strongly positive (5ϩ) nitrate score, had a semiquantitative catalase score of Ͼ45 mm, had a negative arylsulfatase at 3 and 14 days, was urease negative, was positive for Tween hydrolysis, and did not reduce tellurite (3) . The isolate has been submitted to the Collection de l'Institut Pasteur (CIP) (CIP110918) and the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) (DSM 100883).
